Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
HRD + BRCA2 mutation
i
Other names:
BRCA2, BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, Breast cancer 2, early onset, HRD, Homologous Recombination Deficiency
Associations
(7)
News
Trials
A2 | Sensitive
C3 | Sensitive
A2 | Resistant
C3 | Resistant
Show legend
Drug categories
PARP Inhibitors
Tyrosine Kinase Inhibitors
Cancel
Ovarian Cancer
Fallopian Tube Cancer
Peritoneal Cancer
Endometrial Cancer
bevacizumab + olaparib
A2
HRD + BRCA2 mutation
|
Ovarian Cancer
|
bevacizumab + olaparib
A2
HRD + BRCA2 mutation
|
Fallopian Tube Cancer
|
bevacizumab + olaparib
A2
HRD + BRCA2 mutation
|
Peritoneal Cancer
|
bevacizumab + olaparib
niraparib
C3
HRD + BRCA2 mutation
|
Ovarian Cancer
|
niraparib
C3
HRD + BRCA2 mutation
|
Fallopian Tube Cancer
|
niraparib
C3
HRD + BRCA2 mutation
|
Peritoneal Cancer
|
niraparib
C3
HRD + BRCA2 mutation
|
Endometrial Cancer
|
niraparib
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
